Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk

[1]  X. Gu,et al.  Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. , 2010, Human immunology.

[2]  P. Bugert,et al.  A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk , 2010, Breast Cancer Research and Treatment.

[3]  Rondi A. Butler,et al.  Mature MicroRNA Sequence Polymorphism in MIR196A2 Is Associated with Risk and Prognosis of Head and Neck Cancer , 2010, Clinical Cancer Research.

[4]  Bo Liu,et al.  MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. , 2009, Lung cancer.

[5]  C. Croce.  Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.

[6]  D. Hutton,et al.  Assessing risk communication in breast cancer: are continuous measures of patient knowledge better than categorical? , 2009, Patient education and counseling.

[7]  I. Ellis,et al.  MicroRNA involvement in the pathogenesis and management of breast cancer , 2009, Journal of Clinical Pathology.

[8]  H. Brenner,et al.  Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology. , 2009, Cancer research.

[9]  Klaus Rajewsky,et al.  MicroRNA Control in the Immune System: Basic Principles , 2009, Cell.

[10]  Hua Zhao,et al.  A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. , 2008, Carcinogenesis.

[11]  N. Rajewsky,et al.  Widespread changes in protein synthesis induced by microRNAs , 2008, Nature.

[12]  D. Bartel,et al.  The impact of microRNAs on protein output , 2008, Nature.

[13]  Zhenbao Yu,et al.  Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs. , 2008, Carcinogenesis.

[14]  Ru-Fang Yeh,et al.  miR-126 regulates angiogenic signaling and vascular integrity. , 2008, Developmental cell.

[15]  Ryan M. O’Connell,et al.  MicroRNAs: new regulators of immune cell development and function , 2008, Nature Immunology.

[16]  H. Brenner,et al.  Epigenotyping in Peripheral Blood Cell DNA and Breast Cancer Risk: A Proof of Principle Study , 2008, PloS one.

[17]  Barbara Jarzab,et al.  Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma , 2008, Proceedings of the National Academy of Sciences.

[18]  C. Croce,et al.  MiR-15a and miR-16-1 cluster functions in human leukemia , 2008, Proceedings of the National Academy of Sciences.

[19]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[20]  Michael A. Beer,et al.  Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. , 2007, Molecular cell.

[21]  T. Golub,et al.  Impaired microRNA processing enhances cellular transformation and tumorigenesis , 2007, Nature Genetics.

[22]  Peng Jin,et al.  Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. , 2007, Human molecular genetics.

[23]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[24]  E. Furth,et al.  Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster , 2006, Nature Genetics.

[25]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[26]  Michael Zuker,et al.  DINAMelt web server for nucleic acid melting prediction , 2005, Nucleic Acids Res..

[27]  Kathryn A. O’Donnell,et al.  c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.

[28]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[29]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[30]  F. Slack,et al.  RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.

[31]  B. Cullen,et al.  MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Hermann Brenner,et al.  Provider delay among patients with breast cancer in Germany: a population-based study. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  R. Russell,et al.  bantam Encodes a Developmentally Regulated microRNA that Controls Cell Proliferation and Regulates the Proapoptotic Gene hid in Drosophila , 2003, Cell.

[34]  Douglas F. Easton,et al.  Polygenic susceptibility to breast cancer and implications for prevention , 2002, Nature Genetics.

[35]  A. Meindl,et al.  Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population , 2002, International journal of cancer.

[36]  T. Key,et al.  Epidemiology of breast cancer. , 2001, The Lancet. Oncology.

[37]  W D Plummer,et al.  Power and sample size calculations for studies involving linear regression. , 1998, Controlled clinical trials.

[38]  Illinois.,et al.  Cancer Genetics , 1976, British Journal of Cancer.

[39]  Jin Young Park,et al.  Prognostic impact of microRNA-related gene polymorphisms on survival of patients with colorectal cancer , 2009, Journal of Cancer Research and Clinical Oncology.

[40]  P. Bugert,et al.  A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. , 2009, Carcinogenesis.

[41]  Bruce A.J. Ponder,et al.  Cancer genetics , 2001, Nature.

[42]  Peter Beighton,et al.  de la Chapelle, A. , 1997 .